Table of Contents
<< Previous Issue | Sep 2013 (Vol: 2013, Issue: 9) | Next Issue >> |
- Section: Licensing
-
Orphan Drug Developer Ultragenyx Licenses Kyowa Hakko Kirin’s X-Linked Hypophosphataemia Drug
-
Roche Looks to Combination Immunotherapies with Inovio DNA Vaccine Collaboration
- Section: Mergers & Acquisitions
-
Amgen and Onyx Finally Agree to US$10.4 B Takeover
-
Astex Accepts Takeover Offer from Otsuka Regarded As Too Low By Many
-
Cornerstone Therapeutics Accepts Sweetened Buyout Offer from Majority Shareholder Chiesi